基本信息 产品详情 公司简介 推荐产品
网站主页 磷酸化P44/42 MAPK(ERK1/2)(THR202/TYR204)抗体 磷酸化p44/42 MAPK(Erk1/2)(Thr202/Tyr204)抗体
  • 磷酸化p44/42 MAPK(Erk1/2)(Thr202/Tyr204)抗体-9101
  • 磷酸化p44/42 MAPK(Erk1/2)(Thr202/Tyr204)抗体-9101
  • 磷酸化p44/42 MAPK(Erk1/2)(Thr202/Tyr204)抗体-9101
  • 磷酸化p44/42 MAPK(Erk1/2)(Thr202/Tyr204)抗体-9101

1/4

磷酸化p44/42 MAPK(Erk1/2)(Thr202/Tyr204)抗体-9101

现货
Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) Antibody
¥6910 200ul 起订
¥15390 600ul 起订
上海 更新日期:2026-11-17

上海优宁维生物科技股份有限公司

VIP6年
联系人:王
电话:15921930842拨打
手机:15921930842 拨打
邮箱:yh-wang@univ-bio.com

产品详情:

中文名称:
磷酸化p44/42 MAPK(Erk1/2)(Thr202/Tyr204)抗体
英文名称:
Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) Antibody
品牌:
CST
产品类别:
其他生物试剂
货号:
9101
一、产品概述

磷酸化p44/42 MAPK(Erk1/2)(Thr202/Tyr204)抗体 是来自CST品牌的高品质产品,适用于科研实验领域。

更多产品描述请查看优宁维官网(https://www.univ-bio.com/p44-mapk/9101S.html?mk_channel=chemicalbook)

二、产品信息
货号9101
SKU货号9101L
品牌CST
中文名称磷酸化p44/42 MAPK(Erk1/2)(Thr202/Tyr204)抗体
英文名称Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) Antibody
分子量42, 44
抗原名称p4442 MAPK
来源纯化

Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Thr202/Tyr204 of human p44 MAP kinase.
研究领域癌症,细胞生物学,神经科学
商品描述

Product Usage Information

Application Dilution
Western Blotting 1:1000
Simple Western™ 1:10 - 1:50
Immunoprecipitation 1:50
Immunofluorescence (Immunocytochemistry) 1:200 - 1:800
Flow Cytometry (Fixed/Permeabilized) 1:100 - 1:400
三、背景
研究领域癌症,细胞生物学,神经科学
背景

Background

Mitogen-activated protein kinases (MAPKs) are a widely conserved family of serine/threonine protein kinases involved in many cellular programs, such as cell proliferation, differentiation, motility, and death. The p44/42 MAPK (Erk1/2) signaling pathway can be activated in response to a diverse range of extracellular stimuli, including mitogens, growth factors, and cytokines (1-3), and research investigators consider it an important target in the diagnosis and treatment of cancer (4). Upon stimulation, a sequential three-part protein kinase cascade is initiated, consisting of a MAP kinase kinase kinase (MAPKKK or MAP3K), a MAP kinase kinase (MAPKK or MAP2K), and a MAP kinase (MAPK). Multiple p44/42 MAP3Ks have been identified, including members of the Raf family, as well as Mos and Tpl2/COT. MEK1 and MEK2 are the primary MAPKKs in this pathway (5,6). MEK1 and MEK2 activate p44 and p42 through phosphorylation of activation loop residues Thr202/Tyr204 and Thr185/Tyr187, respectively. Several downstream targets of p44/42 have been identified, including p90RSK (7) and the transcription factor Elk-1 (8,9). p44/42 are negatively regulated by a family of dual-specificity (Thr/Tyr) MAPK phosphatases, known as DUSPs or MKPs (10), along with MEK inhibitors, such as U0126 and PD98059.
  1. Roux, P.P. and Blenis, J. (2004) Microbiol Mol Biol Rev 68, 320-44.
  2. Baccarini, M. (2005) FEBS Lett 579, 3271-7.
  3. Meloche, S. and Pouysségur, J. (2007) Oncogene 26, 3227-39.
  4. Roberts, P.J. and Der, C.J. (2007) Oncogene 26, 3291-310.
  5. Rubinfeld, H. and Seger, R. (2005) Mol Biotechnol 31, 151-74.
  6. Murphy, L.O. and Blenis, J. (2006) Trends Biochem Sci 31, 268-75.
  7. Dalby, K.N. et al. (1998) J Biol Chem 273, 1496-505.
  8. Marais, R. et al. (1993) Cell 73, 381-93.
  9. Kortenjann, M. et al. (1994) Mol Cell Biol 14, 4815-24.
  10. Owens, D.M. and Keyse, S.M. (2007) Oncogene 26, 3203-13.

Alternate Names

ERK; ERK-1; ERK-2; ERK1; ERK2; ERT1; ERT2; Extracellular signal-regulated kinase 1; Extracellular signal-regulated kinase 2; extracellular signal-regulated kinase-2; extracellular signal-related kinase 1; HS44KDAP; HUMKER1A; Insulin-stimulated MAP2 kinase; MAP kinase 1; MAP kinase 2; MAP kinase 3; MAP kinase isoform p42; MAP kinase isoform p44; MAPK 1; MAPK 2; MAPK 3; MAPK1; MAPK2; MAPK3; MGC20180; Microtubule-associated protein 2 kinase; Mitogen-activated protein kinase 1; Mitogen-activated protein kinase 2; Mitogen-activated protein kinase 3; MK01; MK03; p38; p40; p41; p41mapk; p42-MAPK; P42MAPK; p44-ERK1; p44-MAPK; P44ERK1; P44MAPK; PRKM1; PRKM2; PRKM3; protein tyrosine kinase ERK2

四、制备和贮存
保存方式
Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C. Do not aliquot the antibody.
五、应用
反应种属Human,Mouse,Rat,Hamster,Monkey,Mink,D. melanogaster,Zebrafish,Bovine,Pig,C. elegans,
敏感性Endogenous
目标/特异性

Specificity / Sensitivity

Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) Antibody detects endogenous levels of p44 and p42 MAP Kinase (Erk1 and Erk2) when phosphorylated either individually or dually at Thr202 and Tyr204 of Erk1 (Thr185 and Tyr187 of Erk2). This antibody does not cross-react with the corresponding phosphorylated residues of either JNK/SAPK or p38 MAP Kinase, and does not cross-react with non-phosphorylated Erk1/2.

Species Reactivity:

Human, Mouse, Rat, Hamster, Monkey, Mink, D. melanogaster, Zebrafish, Bovine, Pig, C. elegans

The antigen sequence used to produce this antibody shares 100% sequence homology with the species listed here, but reactivity has not been tested or confirmed to work by CST. Use of this product with these species is not covered under our Product Performance Guarantee.

Species predicted to react based on 100% sequence homology:

Chicken
六、产品特点
  • 品质保证:经过严格的质量控制,确保产品的高品质和稳定性。
七、注意事项
  • 本产品仅供科学研究使用,不可用于临床诊断或治疗。
  • 请在通风良好的环境下操作,佩戴适当的个人防护装备。
  • 如不慎接触皮肤或眼睛,请立即用大量清水冲洗并就医。
p44/42 MAPK

公司简介

上海优宁维生物科技股份有限公司(简称:优宁维,股票代码:301166)自2004年成立以来一直专注于抗体及相关产品,是国内专业、全面的抗体供应商和抗体专家,十多年来,正努力发展成为生命科学一站式供应商。公司总部位于上海,全国设有26个办事处,10个境内销售子公司。 我们长期聚焦于生命科学、生物医药、医疗诊断、分析检测等领域,公司整合了国内外50多家行业知名品牌,提供800多万种以抗体为核心的生命科学试剂、耗材、仪器、软件、定制、实验室服务、供应链服务等,形成了以第三方品牌产品为主、自主品牌产品为辅的全面供应体系,为更多的生命科学科研工作者提供专业、全面、安全、快捷的产品和服务。产品覆盖基因、蛋白、细胞、组织、动物等水平的各种研究。 公司2018年建立了南京研发中心,2021年筹建了杭州研发中心,并于2021年在南京投资建设GMP级生产中心,满足更多工业级客户的生命科学试剂需求。 公司秉承 向正 · 向善 · 向上 的价值观,以助力生命科学发展和创新为使命,在世界知名生物制品供应商为愿景下,砥砺前行。

成立日期 (23年)
注册资本 6500.000000万人民币
员工人数 100-500人
年营业额 ¥ 1亿以上
经营模式 试剂,服务,试剂,服务
主营行业 生化试剂,生化试剂,抗体,抗体,蛋白组学,蛋白组学,分子生物学,分子生物学,免疫安全,免疫安全

磷酸化p44/42 MAPK(Erk1/2)(Thr202/Tyr204)抗体相关厂家报价

内容声明
拨打电话 立即询价